NCT03325283 - The PROTEMBO SF Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 9, 2017

Primary Completion Date

August 31, 2018

Study Completion Date

October 30, 2018

Conditions

Aortic Stenosis

Interventions

DEVICE

ProtEmbo Cerebral Protection System

A catheter-based embolic deflection device will be positioned in the arch of the aorta to prevent debris liberated during the TAVR procedure from entering the three major vessels of the aortic arch.

Trial Locations (2)

H91HHTO

Department of Cardiology Galway University Hospital and SAOLTA Healthcare Group, Galway

LV1002

Pauls Stradins Clinical University Hospital, Riga